Novartis chairman floats idea of business review to appease investors

ZURICH (Reuters) – Less than two weeks into the job, Novartis AG’s new chairman is seeking to appease investors by suggesting the Swiss drugmaker will review some of its underperforming businesses in coming weeks.

Powered by WPeMatico

This entry was posted in World News. Bookmark the permalink.

Comments are closed.